Subscribe to RSS
DOI: 10.1055/s-0038-1649479
Positive Association Between Self-Reported Fatty Food Consumption and Factor VII Coagulant Activity, a Risk Factor for Coronary Heart Disease, in 4246 Middle-Aged Men
Publication History
Received 04 September 1992
Accepted after revision 02 February 1993
Publication Date:
04 July 2018 (online)
Summary
Raised levels of factor VII coagulant activity (VIIC) have been reported to increase the incidence of CHD. Preliminary evidence from observational and experimental studies suggests that dietary fat intake is positively associated with VIIC. We explored this further in 4,246 men aged 45–69, who were found to be free of major CHD when screened for a primary prevention trial of antithrombotic medication. All men were asked about their consumption of fatty foods and changes in consumption in the last month.
In the 9% of men who reported avoidance of fatty foods in the month before interview, age adjusted VIIC was 7.8% of standard (95% CI 5.1–10.6%) lower than in the remainder. Serum cholesterol and body mass index (BMI) were also significantly lower. The extent to which fat consumed in the past month had deviated from usual intake was significantly and positively related with VIIC, serum cholesterol and BMI. Thus, the VIIC difference between those eating much less fatty food than usual and those eating much more than usual was 11% of standard, with those eating their usual amount having an intermediate level.
This study adds to the evidence that dietary fat intake influences VIIC and coagulability. The effect is rapid, so that much of the benefit of dietary fat reduction on thrombogenic risk in CHD is likely to occur within a short time. Thus, the results reinforce the value of a low fat diet, even in individuals with advanced atheroma, in whom dietary intervention has sometimes been considered unlikely to be effective.
-
References
- 1 Meade TW, Brozovic M, Chakrabarti RR. et al Haemostatic function and ischaemic heart disease. Principal results of the Northwick Park Heart Study. Lancet 1986; ii: 533-537
- 2 Miller GJ, Wilkes HC, Meade TW, Bauer KA, Batzegar S, Rosenberg RD. Haemostatic changes that constitute the hypercoagulable state. Lancet 1991; ii: 1079
- 3 Lowe GDO. Haemostatic changes and the hypercoagulable state. Lancet 1991; 338: 1526
- 4 Cawalho de SousaJ, Azevedo J, Soria C, Barros R, Ribeiro C, Parreira R, Caen JP. Factor VII hyperactivity in acute myocardial thrombosis. A relation to the coagulation activation. Thromb Res 1988; 51: 165-173
- 5 Suzuki T, Yamauchi K, Matsushita T, Furumichi I, Furui H, Tsuzuki J, Saito H. Elevation in factor VII activity and mass in coronary artery disease of varying severity. Clin Cardiol 1991; 14: 731-736
- 6 Meade TW, Miller GJ, Rosenberg RD. Characteristics associated with the risk of arterial thrombosis and the pre-thrombotic state. In: Thrombosis in Cardiovascular Disorders. Verstraete M, Fuster V. (eds) Philadelphia, PA: WB Saunders; 1991
- 7 Miller GJ, Cruickshank JK, Ellis LJ. et al Fat consumption and factor VII coagulant activity in middle-aged men. Atherosclerosis 1989; 78: 19-24
- 8 Miller GJ, Martin JC, Webster J. et al Association between dietary fat intake and plasma factor VII coagulant activity, a predictor of cardiovascular mortality. Atherosclerosis 1986; 60: 269-277
- 9 Meade TW, Roderick PJ, Brennan PJ, Wilkes JH, Kelleher CC. Extra-cranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation. Thromb Haemostas 1992; 69: 1-6
- 10 Connelly JB, Cooper JA, Meade TW. Strenuous exercise, plasma fibrinogen and factor VII activity. Br Heart J 1992; 67: 351-354
- 11 Brozovic M, Stirling X, Harricks C, North WRS, Meade TW. Factor VII in an industrial population. Br J Haematol 1974; 28: 381-391
- 12 Miller GJ, Martin JC, Mitropolous KA. et al Plasma factor VIIc is activated by postprandial triglyceridaemia irrespective of dietary fat consumption. Atherosclerosis 1991; 86: 163-171
- 13 Mitropoulos KA, Miller GJ, Reeves BEA, Wilkes HC, Cruickshank JK. Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle aged men. Atherosclerosis 1989; 76: 203-208
- 14 Mitropoulos KA, Miller GJ, Watts GR, Durrington PN. Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: a study in familial lipoprotein lipase deficiency. Atherosclerosis 1992; 95: 119-125
- 15 Mitropoulos KA, Esnouf MP. The prothrombin activation peptide regulates synthesis of the vitamin K-dependent proteins in the rabbit. Thromb Res 1990; 57: 541-549
- 16 Keys A. Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease. Cambridge, MA: Harvard University Press; 1980
- 17 Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979; 60: 473-485
- 18 Wilkes HC, Meade TW, Barzegar S. et al Gemfibrozil reduces plasma prothrombin fragment F1 + 2 corrcertration, a marker of coagulability, in patients with coronary heart disease. Thromb Haemostas 1992; 67: 503-506
- 19 Marckmann P, Sandstrom B, Jespersen J. Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids. Atherosclerosis 1990; 30: 227-233
- 20 Ulbricht TLV, Fouthgate DAL. Coronary heart disease: seven dietary factors. Lancet 1991; 388: 985-992